SBIR/STTR Research Award
An Integrated, Accurate, and Rapid Peanut Allergen Detector for Consumers
Award amount
$1,999,998Program and phase
SBIR · Phase IIAward year
2017Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- NIMA LABS, INC.
- Proposal award date
- 2017-07-01
- Contract end date
- 2019-01-31
- UEI
- Not reported
- Solicitation number
- PA16-302
- Topic code
- NIAID
Research abstract
Pain PointThis Small Business Innovation Research Phase II project proposes to develop an unprecedentedall in one handheld device that integrates food processingassay chemistry and data interpretationthereby
allowing consumers to easily test their food for peanut andin the futureother food allergensFood allergies
are a growing food safety and public health concern in the United StatesGuptaRJAMA PediatricsLiuAHJ Allergy Clin Immunolaffectingof the children underandof adultsReport of the
NIH Expert Panel on Food Allergy ResearchPeanut allergy is the most common cause of food allergyrelated fatalities in the USBockS AJ Allergy Clin ImmunolAmong childrenpeanut is the most
prevalent dietary allergyaccounting forof all food allergiesA strict and lifelong peanut free diet is the
only current treatment for these patientsbut it can be difficult to adhere to because ofacross contamination
during food manufacturing and preparation processes andbinadequate labeling and testing mechanismsRemingtonB CFood Chem ToxicolTraditional peanut tests arecomplicatedmost kits requiresteps and certain steps involve equipment that is not readily available to the usersuch as a scale or grinding
deviceexpensivecosting more than $per testandtime consumingtaking longer thanmin per
testFundamentallythere does not exist a consumer oriented product that peanut sensitive individuals can
use to proactively ensure the safety of their foodTechnological InnovationNima is building the first and only rapid and user friendly solution that enables
consumers to test their food for dietary allergensThe all in onehandheld deviceNimaTMinternally grinds
the foodextracts allergen proteinsspecifically peanut protein under this proposalwith Nima s proprietary
extraction solutionperforms the immunoassay and interprets the resultall withinminutesPerforming all
of these operations internally significantly simplifies the testminimizes opportunities for user error and
variation and builds confidence in the test resultFurtherusers will have the option to automatically upload
test results via Bluetooth to a mobile app that Nima is buildingResults will be collected by both consumers
and the Nima team and automatically entered into a databaseNima aims to build the largest living allergenand glutentest result database in the USwhich will serve as a resource to the community living with food
allergiesso that consumers can make smarter decisions about where and what to eatBroader Impacts of the Technology are to provide food sensitive individualstheir parents or other
caregivershealth care providers and food manufacturers with an easy means of testing foodsensuring food
safety and improving healthWhile Nima s first productnow on the marketfocused on gluten detection and
the second will focus on peanut detectionthis technology platform is expected to expand to the detection of
other common food allergens or irritantsincluding tree nutsdairy productseggs and soyamong others
Technology keywords
Not reported
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Manufacturing and Formulation Process Development for a Prophylactic Cholera Phage Cocktail
- A first-in-class product for the clearance of high-risk human papillomaviruses
- A Rapid, Point-of-Care Diagnostic to Identify Viable Sexually Transmitted Infections, Reduce Overtreatment, and Prevent Emerging Antibiotic Resistance
- Optimization, Pharmacokinetics, and Efficacy of an IgG Protease for the Treatment of Immune Thrombocytopenia and Other IgG-Mediated Autoimmune Diseases
- Nebulized ALX1 as a treatment for Pseudomonas aeruginosa infections in bronchiectasis patients